Chart-Typ:
Zeitraum:
| Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership | Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy... ► Artikel lesen |
| ROUNDUP/Aktien New York Schluss: Chipwerte belasten Nasdaq | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA wieder einmal geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen |
| Aktien New York: Chipwerte belasten Nasdaq - US-Pläne gegen Iran bewegen kaum | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA erneut geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen |
| XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -3- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameKYG200801002 CBAK... ► Artikel lesen |
| Akari Therapeutics Plc: Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers | Patent filing covers PH1 payload's unique ability to disrupt multiple cancer-driving pathways in addition to its overall cytotoxic mechanism Expands intellectual property portfolio supporting Akari's... ► Artikel lesen |
| Akari Therapeutics Plc: Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy | AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari's novel PH1 RNA spliceosome-modulating... ► Artikel lesen |
| Laser Photonics Corp.: Laser Photonics Announces Closing of $7.9 Million Public Offering | ORLANDO, FL / ACCESS Newswire / September 15, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a developer of laser systems for industrial and defense applications, today announced... ► Artikel lesen |
| Laser Photonics Corp.: Laser Photonics Announces Pricing of $7.9 Million Public Offering | ORLANDO, FL / ACCESS Newswire / September 10, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a developer of laser systems for industrial and defense applications, today announced... ► Artikel lesen |
| Laser Photonics Corp.: Laser Photonics Receives Repeat Order from Established Canadian Manufacturer for Beamer B-Series Laser Marking System | ORLANDO, FL / ACCESS Newswire / September 3, 2026 / Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a developer of laser systems for industrial and defense applications... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu REAL MESSENGER CORPORATION finden Sie auf Wallstreet Online.